The Effect of Coconut Oil on Alopecia
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
About this trial
İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
• To have been diagnosed with breast cancer.
The chemotherapy treatment plan should be planned as the Doxorubicin-Cyclophosphamide protocol.
Volunteer to participate in the study.
Be 18 years of age or older.
Disqualifiers
• Having any health problem or disability that prevents communication (vision-hearing problems, neurological, psychiatric diseases).
Planning other treatments other than the Doxorubicin-Cyclophosphamide protocol for the treatment of breast cancer.
Not volunteering to participate in the study.
Having previously experienced any disease/skin problem that causes hair loss.
Trial design
Design model
Parallel
Treatments tested in this trial
Coconut Oil
Other interventionThe coconut oil application protocol will be explained to the patients in the experimental group and 10 milliliters of coconut oil will be applied to the hair follicles once a week. Alopecia assessment will be done every week.
Treatment groups
86 Participants
are divided into 2 treatment groupsGroup A: Experimental groupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
National Cancer Instute (NCI) Common Terminology Criteria for Adverse Events (CTCAE); Alopecia
Grade 1; Hair loss of \<50% of normal for that individual that is not obvious from a distance but only on close inspection; a different hair style may be required to cover the hair loss but it does not require a wig or hair piece to camouflage Grade 2; Hair loss of \>=50% normal for that individual that is readily apparent to others; a wig or hair piece is necessary if the patient desires to completely camouflage the hair loss; associated with psychosocial impact
Time frame
1-12 WEEKSponsors and contacts
Click on the lead sponsor to view all of their trials.
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Lead sponsor
Çankırı Karatekin University
Collaborator
Source ClinicalTrials.gov